Atrial Fibrillation– Novel Oral Anticoagulants (NOACS) as a therapeutic option.

dc.contributor.author	Paherathy, A.
dc.contributor.author	Suramiya, A.A.A.
dc.contributor.author	Thivacaren, S.
dc.contributor.author	Shiyananth, S.
dc.contributor.author	Arasalingam, A.
dc.date.accessioned	2022-09-26T05:40:46Z
dc.date.available	2022-09-26T05:40:46Z
dc.date.issued	2021
dc.identifier.citation	Proceedings JMA, October 2021	en_US
dc.identifier.uri	http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/7511
dc.language.iso	en	en_US
dc.publisher	Jaffna Medical Association	en_US
dc.subject	Atrial fibrillation	en_US
dc.subject	Novel Oral Anticoagulants (NOACS)	en_US
dc.title	Atrial Fibrillation– Novel Oral Anticoagulants (NOACS) as a therapeutic option.	en_US
dc.type	Research abstract	en_US